In transgenic Apc+/∆716/Smad4+/- compound knockout mice that develop CRC, CCL9 is secreted from cancer cells, which recruits CCR1+ myeloid cells to promote tumor invasion [10]. The gene discussed is SMAD4; the disease is cancer.